Researcher biography

Hana Starobova is postdoctoral researcher at the Sensory Neuropharmacology Group at the University of Queensland. Hana's work focusses on the development of mechanism-based treatments and prevention strategies for chemotherapy induced side effects with the main focus on peripheral neuropathy and gastrointestinal side effects. Hana was the first to discover that the Nod-like receptor 3 (NLRP3) activation and release of interleukin one beta drives the development of vincristine-induced neuropathy and the inhibition of those pathways effectively prevents the development of this debilitating side effect (JEM, 2021). Hana is an internationally recognised expert, and she has extensive experience in pharmacology, innate immunology, transcriptomics, peripheral pain mechanisms, rodent behavioural studies, target identification, development of new in vivo models and in vitro techniques and high throughput calcium imaging. Moreover, her expertise includes the isolation and state of the art imaging of neuronal tissues. The quality of her research is evidenced by her track record, that is extraordinary for an early career researcher with a total of 13 publications (all Q1 journals) in the last 5 years which have attracted vast attention of media. Hana has received 10 awards, including the 2019 Women in Technology, Young Achiever Award and the University of Queensland Career Development Award. Recently, Hana has participated in Antarctic expedition with the Homeward Bound Project.